But when chlorotoxin binds to MMP-2, both get drawn into the cancerous cell. Other researchers are currently conducting human trials using chlorotoxin to slow cancer's spread.

Biologists have described the capacity of a small protein (a peptide) derived from chlorotoxin, found in scorpion venom (Giant Yellow Israeli scorpion), to carry drugs across the blood-brain ...

Chlorotoxin passed a phase II clinical trial in 2009. More recently, the peptide has become the key ingredient in an experimental surgical tool called Tumor Paint.

INB-300 is our DeltEx DRI Chlorotoxin CAR-T preclinical candidate that combines our expertise in gamma-delta T cells, our DeltEx DRI technology and a novel Chlorotoxin targeting CAR.

Chimeric Therapeutics Ltd.‘s chlorotoxin (CLTX) CAR T therapy, CHM-1101, which is derived from scorpion toxin, saw a disease control rate of 55%, exceeding the historical disease control rates of 20% ...

Cell therapy-focused company Chimeric Therapeutics Limited (ASX: CHM) has received a patent allowance in Japan for application JP2022007016A, which includes specific applications of chimeric antigen ...

The Peptides and Proteins lab at the Institute for Research in Biomedicine (IRB Barcelona) has published a paper in Chemical Communications describing the capacity of a small protein (a peptide) ...

BioWorld Content on 'chlorotoxin'In the Marvel Comic Universe, Venom is a superhero who started life as a supervillain and Spiderman foe. In the biopharma universe, scorpion venom is undergoing the ...